Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:10 PM EDT
Neurocrine Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 687.5M | 572.6M | 627.7M | 622.1M | 590.2M | 515.3M | 515.2M | 498.8M | 452.7M | 420.4M | 412M | 387.9M | 378.2M | 310.6M | 312M | 296M | 288.9M | 236.6M |
Cost of Revenue | 11.3M | 9.2M | 9.3M | 8M | 15.6M | 12.8M | 8.5M | 11.2M | 11.5M | 8.5M | 7.7M | 6.1M | 4.8M | 4.6M | 4.1M | 4.2M | 3.1M | 2.9M |
Gross Profit | 676.2M | 563.4M | 618.4M | 614.1M | 574.6M | 502.5M | 506.7M | 487.6M | 441.2M | 411.9M | 404.3M | 381.8M | 373.4M | 306M | 307.9M | 291.8M | 285.8M | 233.7M |
Operating Income | 145.6M | 23.6M | 142M | 183.8M | 147.9M | 105.3M | 150.3M | 141.2M | 73.6M | -114.2M | 103.4M | 87.8M | 54.7M | 3.1M | -36.3M | 44.5M | 62.8M | 31.5M |
Interest Income | 20.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 159.5M | 14.7M | 162.6M | 190.3M | 98.6M | 34.5M | 198.2M | 115.6M | 121.6M | -103.3M | 117.9M | 97.9M | -23.3M | 21.4M | -13.8M | 30.5M | 57.5M | 27.2M |
Net Income | 107.5M | 7.9M | 103.1M | 129.8M | 65M | 43.4M | 147.7M | 83.1M | 95.5M | -76.6M | 89M | 68.5M | -16.9M | 13.9M | -7.3M | 22.5M | 42.3M | 32.1M |
Selling & General & Admin | 286.3M | 276.5M | 287.8M | 234.3M | 242M | 243.1M | 218.9M | 204.2M | 221.8M | 242.7M | 182.9M | 186.3M | 182.8M | 200.7M | 156.5M | 154.6M | 143.2M | 129M |
Research & Development | 244.3M | 263.2M | 185.6M | 195M | 184.7M | 154.1M | 137.5M | 142.2M | 145.8M | 139.5M | 118M | 107.7M | 135.9M | 102.2M | 87.4M | 92.7M | 74.8M | 73.2M |
Other Expenses | n/a | 100K | 3M | 1M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 530.6M | 539.8M | 476.4M | 430.3M | 426.7M | 397.2M | 356.4M | 346.4M | 367.6M | 382.2M | 300.9M | 294M | 318.7M | 302.9M | 243.9M | 247.3M | 218M | 202.2M |
Interest Expense | n/a | n/a | n/a | n/a | 49.7M | 1.1M | 1.1M | 1.1M | 1.3M | 1.1M | 1.1M | 1.2M | 2.2M | 2.6M | 6.6M | 6.6M | 6.2M | 6.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 541.9M | 549M | 494.2M | 438.3M | 442.3M | 410M | 364.9M | 357.6M | 379.1M | 390.7M | 308.6M | 300.1M | 323.5M | 307.5M | 248M | 251.5M | 221.1M | 205.1M |
Income Tax Expense | 52M | 6.8M | 59.5M | 60.5M | 33.6M | -8.9M | 50.5M | 32.5M | 26.1M | -26.7M | 28.9M | 29.4M | -6.4M | 7.5M | -6.5M | 8M | 15.2M | -4.9M |
Shares Outstanding (Basic) | 99M | 99.7M | 100M | 101.1M | 100.8M | 99.8M | 98.4M | 97.9M | 97.6M | 97.1M | 96.3M | 95.8M | 95.6M | 95.3M | 94.9M | 94.7M | 94.6M | 94.2M |
Shares Outstanding (Diluted) | 101M | 102.5M | 102.9M | 104.3M | 103.9M | 103.6M | 102.3M | 101.1M | 100.2M | 97.1M | 100.8M | 99M | 95.6M | 97.6M | 94.9M | 97.7M | 97.7M | 98.2M |
EPS (Basic) | 1.09 | 0.08 | 1.03 | 1.28 | 0.64 | 0.43 | 1.50 | 0.85 | 0.98 | -0.79 | 0.92 | 0.72 | -0.18 | 0.15 | -0.08 | 0.24 | 0.45 | 0.34 |
EPS (Diluted) | 1.06 | 0.08 | 1.00 | 1.24 | 0.63 | 0.42 | 1.44 | 0.82 | 0.95 | -0.79 | 0.88 | 0.69 | -0.18 | 0.14 | -0.08 | 0.23 | 0.43 | 0.33 |
EBITDA | 166.8M | 31.3M | 169.7M | 191.3M | 155.2M | 111.5M | 156M | 146.7M | 78.7M | -97.2M | 107.8M | 91.8M | -17.2M | 6.4M | -4.2M | 47.3M | 70.4M | 34M |
EBIT | 159.5M | 23.7M | 162.6M | 184.8M | 147.9M | 124.3M | 150.3M | 141.2M | 121.6M | -102.2M | 103.4M | 87.8M | 54.7M | 24M | -7.2M | 44.5M | 67.8M | 31.5M |
Depreciation & Amortization | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M | 6.2M | 5.7M | 5.5M | 5.1M | 5M | 4.4M | 4M | 3.9M | 3.3M | 3M | 2.8M | 2.6M | 2.5M |